The procedure, carried out in Damaturu, represents the first time such an advanced maxillofacial surgery has been conducted in a state-owned hospital in the region.
The launch brings together national and international health stakeholders who are supporting Nigeria’s broader HIV response strategy.
The Sokoto deployment builds on findings from an extensive randomized controlled implementation study conducted in Nigeria in collaboration with PATH, Jhpiego, the National Primary Health Care Development Agency, and Sydani Group.
The project received financial backing from First City Monument Bank (FCMB) and the Bank of Industry (BoI), reflecting a coordinated push to support local industry growth.
Lenacapavir complements existing prevention methods such as oral pre-exposure prophylaxis and long-acting injectable cabotegravir.
Trained health workers will conduct house-to-house visits and set up vaccination points at designated community locations to maximise coverage.
The Global Fund has provided USD 3 million for governance and capacity building, along with USD701 million in programmatic funding.
The warning comes after an official report from Roche Nigeria, which traced the fake products bearing batch number N2110A09 in Kaduna and Gombe States.
The alert followed official communication from Roche Nigeria after the pharmaceutical company received multiple complaints from healthcare professionals nationwide.
The complaints originated from Lagos University Teaching Hospital (LUTH-NSIA), where patients brought in suspected counterfeit products for administration.